Lv1
10 积分 2023-10-17 加入
Multi-omics models for predicting prognosis in non-small cell lung cancer patients following chemotherapy and radiotherapy: A multi-center study
2天前
已完结
Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?
2天前
求助中
Spatial biology captures the effects of neoadjuvant chemo-immunotherapy in lung cancer
4天前
已完结
Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled trials
13天前
已完结
Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?
15天前
已关闭
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysis
15天前
已完结
Why and When Do We Invasively Restage After Neoadjuvant Chemoimmunotherapy?
23天前
已关闭
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
1个月前
已完结
IL‐1β‐Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up‐regulating Programmed Death Ligand 1 and Colony‐Stimulating Factor 1
2个月前
已完结
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
2个月前
已完结
皖公网安备34019202002308
